| Product Code: ETC7658387 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel`s import of pancrelipase saw a diverse range of top exporting countries including Switzerland, UK, Belgium, USA, and Germany. The Herfindahl-Hirschman Index (HHI) indicated low market concentration, suggesting a competitive landscape. Despite a negative compound annual growth rate (CAGR) of -2.14% from 2020 to 2024, the growth rate improved slightly in 2024 with a decrease of only -0.41% compared to the previous year. This data highlights the steady but challenging market conditions for pancrelipase imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pancrelipase Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pancrelipase Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pancrelipase Market - Industry Life Cycle |
3.4 Israel Pancrelipase Market - Porter's Five Forces |
3.5 Israel Pancrelipase Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.6 Israel Pancrelipase Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Pancrelipase Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Pancrelipase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pancreatic disorders and diseases in Israel |
4.2.2 Growing awareness about the benefits of pancrelipase in managing pancreatic insufficiency |
4.2.3 Rising healthcare expenditure in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost associated with pancrelipase medications |
4.3.3 Limited availability of specialized healthcare professionals for pancreatic care in Israel |
5 Israel Pancrelipase Market Trends |
6 Israel Pancrelipase Market, By Types |
6.1 Israel Pancrelipase Market, By Age |
6.1.1 Overview and Analysis |
6.1.2 Israel Pancrelipase Market Revenues & Volume, By Age, 2021- 2031F |
6.1.3 Israel Pancrelipase Market Revenues & Volume, By Children, 2021- 2031F |
6.1.4 Israel Pancrelipase Market Revenues & Volume, By Adults and Geriatrics, 2021- 2031F |
6.2 Israel Pancrelipase Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Pancrelipase Market Revenues & Volume, By Chronic Pancreatitis, 2021- 2031F |
6.2.3 Israel Pancrelipase Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.4 Israel Pancrelipase Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Pancrelipase Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Pancrelipase Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.3 Israel Pancrelipase Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.4 Israel Pancrelipase Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
7 Israel Pancrelipase Market Import-Export Trade Statistics |
7.1 Israel Pancrelipase Market Export to Major Countries |
7.2 Israel Pancrelipase Market Imports from Major Countries |
8 Israel Pancrelipase Market Key Performance Indicators |
8.1 Patient adherence rates to pancrelipase treatment |
8.2 Number of clinical trials and research studies conducted on pancrelipase in Israel |
8.3 Adoption rate of advanced pancrelipase formulations |
8.4 Patient satisfaction and reported quality of life improvements with pancrelipase therapy |
9 Israel Pancrelipase Market - Opportunity Assessment |
9.1 Israel Pancrelipase Market Opportunity Assessment, By Age, 2021 & 2031F |
9.2 Israel Pancrelipase Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Pancrelipase Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Pancrelipase Market - Competitive Landscape |
10.1 Israel Pancrelipase Market Revenue Share, By Companies, 2024 |
10.2 Israel Pancrelipase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |